Cardlytics Inc (CDLX) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access CDLX Annual Cash Flow →
This cash flow overview for Cardlytics Inc spans from Jun 30 2025 to Jun 30 2026, illustrating how cash generation and usage have shifted across recent reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
6 Months
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-41.81
Depreciation & amortization16.48
Amortization of Other Assets0.30
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability0.00
Provision For Loan Losses Expensed0.77
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Business0.00
Share-based Compensation7.18
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Fair Value Adjustment Of Convertible Promissory Notes-
Fair Value Adjustment Of Convertible Promissory Notes Related Parties-
Increase Decrease In Deferred Financial Institution Implementation Costs-
Increase Decrease In Financial Institution Share Liability-7.24
Capitalized Contract Cost Amortization-
Capitalized Contract Cost Amortization Interest Expense0.33
Restricted Cash And Cash Equivalents-
Finance Lease Right Of Use Asset Amortization0.32
Contract with Customer Asset Deferred Implementation Costs Amortization-
Income Tax Expense Benefit-
Property And Equipment Incurred But Not Yet Paid-
Capitalized Software Development Costs Incurredbut Notyet Paid-
Goodwill And Intangible Asset Impairment-
Increase Decrease In Consumer Incentive Liability-11.55
Income taxes0.00
Gain (Loss) on Investments-4.79
Increase (Decrease) in Accounts Receivable-13.22
Increase (Decrease) in Accounts Payable-2.16
Increase (Decrease) in Accrued Liabilities2.26
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.57
Other Working Capital0.00
Other Noncash Income (Expense)-1.58
Other net0.00
Payments for (Proceeds from) Other Operating Activities19.80
Discontinued operations3.10
Net Cash flow from Operating Activities-14.24
Investing Activities
Capital Expenditures-4.41
Sale of Capital Items0.00
Short-term Investments Proceeds23.03
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Proceeds from Divestiture of Businesses, Net of Cash Divested0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities18.62
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-0.03
Long-term debt - borrowings5.00
Long-term debt - repayments-30.07
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-0.20
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.20
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents48.72
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-25.10
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-18.65
Total Cash Flow-20.68
4 historic quarters locked

Sign in to unlock the full Cardlytics Inc cash flow history.

About Cardlytics Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628280-26-053340

Figures are derived from filed reports and may be restated. Historical data is subject to revision.